“STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS”. Research Focus International Scientific Journal, vol. 2, no. 1, Feb. 2023, pp. 11-19, https://doi.org/10.66073/researchfocus.v2i1.2819.